A 41-year-old female patient was referred following a brain magnetic resonance imaging (MRI) scan for the diagnostic work-up of new-onset ''burning'' headaches and increasing fatigue. MRI showed multiple acute and subacute T2-hyperintensities, suggesting a proximal embolic source or possibly vasculitis (Online Resource 1). Routine blood results, spinal fluid analysis, and conventional angiography were unremarkable. Transesophageal echocardiography (TEE) revealed a 5.2 9 2.6 mm left atrial tumor. The tumor was resected, and histologic examination confirmed the diagnosis of a cardiac myxoma (Fig. 1a, b) .
After an uneventful postoperative period, the patient reported the new onset of pounding headaches about one year later. Follow-up MRI demonstrated the presence of microbleeds and multiple fusiform aneurysms (Fig. 2a) . TEE was repeated, but no recurrence of the cardiac myxoma was found. At the same time, the patient suffered from recurrent simple focal seizures and a mild sensorimotor paralysis of the left arm. Angiography now revealed the presence of multiple fusiform aneurysms (Fig. 2g) . Biopsy of the largest aneurysm in the right pre-central region demonstrated intramural and intravascular collections of neoplastic spindle cells embedded in myxoid material, along with blood extravasation and perivascular lymphoplasmacytic infiltrates consistent with metastatic emboli of the previously resected ([ 1year before) cardiac myxoma (Fig. 1c) . Five months later, the patient reported progressive loss of function of the left hand and severe burning headaches. Follow-up MRI demonstrated a dramatic progression of the aneurysms and hemorrhages (Fig. 2b ). 18F-Ethyltyrosine (FET)-PET showed metabolic activity within the largest aneurysm, suggestive of a neoplastic focus ( administered over a three-day period, in addition to 4 mg/d dexamethasone was started. After two cycles, the patient showed major clinical improvement. MRI confirmed a reduction in hematoma volumes and brain edema, and stable aneurysm size (Fig. 2c) . However, two months after conclusion of six cycles of etoposide/carboplatin, administered in 4-week intervals, a control MRI again revealed increased size and contrast enhancement as well as edema progression of the largest right pre-central aneurysmatic lesion (Fig. 2d) . To prevent further damage from bleeding and pressure effects, this lesion was surgically resected (Fig. 2e) . The resected tissue specimen revealed ongoing myxoma invasion and an even more pronounced inflammatory reaction (Fig. 1d-g ). Therefore, three weeks after surgery, the patient was started on immunosuppressive and anti-inflammatory therapy with i.v. cyclophosphamide (600 mg/m 2 body surface area). She has received four cycles so far, and remains clinically stable on 1.5 mg dexamethasone, which will be slowly tapered off. Recent angiography and MRI have confirmed stable aneurysm size and distribution (Fig. 2f, j) .
In cases of severe neurological impairment due to multifocal myxomatous aneurysms, where a wait-and-see strategy is not a reasonable therapeutic option, chemotherapy may stabilize disease progression. Longer followup is needed to evaluate whether disease control with the cyclophosphamide regimen proves superior to other agents. Conflicts of interest On behalf of all authors, the corresponding author states that there is no conflict of interest.
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